Valuation: Alkem Laboratories Limited

Market Cap 614B 6.54B 5.94B 5.49B 4.96B 9.36B 9.69B 66.02B 26.16B 330B 24.54B 24.02B 1,044B P/E 2027 *
27.5x
P/E 2028 * 23.4x
Enterprise Value 605B 6.44B 5.85B 5.41B 4.88B 9.22B 9.54B 65.02B 25.76B 325B 24.17B 23.66B 1,028B EV / Sales 2027 *
3.61x
EV / Sales 2028 * 3.17x
Free-Float
38.63%
Yield 2027 *
0.98%
Yield 2028 * 1.07%
1 day+0.76%
1 week-5.01%
Current month+1.20%
1 month+3.42%
3 months-3.70%
6 months-5.36%
Current year-6.02%
1 week 5,096
Extreme 5096
5,448
1 month 4,811
Extreme 4811
5,475
Current year 4,811
Extreme 4811
5,933.5
1 year 4,811
Extreme 4811
5,933.5
3 years 4,380.8
Extreme 4380.8
6,439.9
5 years 2,828
Extreme 2828
6,439.9
10 years 1,519
Extreme 1519
6,439.9
Manager TitleAgeSince
President - -
President - -
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 44 2013-08-08
Director/Board Member 63 2008-02-10
Director/Board Member 45 2019-11-10
Change 5-day change 1-year change 3-year change Capi.($)
+0.76%-5.01%-9.58%+16.33% 6.54B
-0.82%+1.40%+39.64%+143.17% 1,275B
-1.12%+0.16%+44.21%+88.24% 680B
-0.16%+0.43%+26.76%+113.01% 521B
-0.38%+1.49%+41.99%+71.63% 389B
-2.23%-2.89%+55.47%+41.64% 356B
-0.89%+0.15%+27.32%+60.14% 305B
-1.05%+0.13%+2.28%+35.50% 287B
-0.72%-0.63%+37.29%+71.87% 250B
-0.30%-1.03%+34.04%+124.88% 208B
Average -0.64%-0.03%+29.94%+76.64% 428B
Weighted average by Cap. -0.73%+0.75%+36.46%+97.41%

Financials

2027 *2028 *
Net sales 167B 1.78B 1.62B 1.5B 1.35B 2.55B 2.64B 17.99B 7.13B 89.8B 6.69B 6.55B 284B 186B 1.98B 1.8B 1.66B 1.5B 2.83B 2.93B 20B 7.92B 99.83B 7.43B 7.28B 316B
Net income 22.95B 244M 222M 205M 185M 350M 362M 2.47B 977M 12.31B 917M 898M 39B 26.82B 286M 260M 240M 217M 409M 423M 2.88B 1.14B 14.39B 1.07B 1.05B 45.6B
Net Debt -9.29B -98.96M -89.91M -83.07M -75.04M -142M -147M -999M -396M -4.99B -371M -363M -15.8B -23.54B -251M -228M -210M -190M -359M -371M -2.53B -1B -12.63B -941M -921M -40.02B
Projected Income Statement - Annual - Alkem Laboratories Limited
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
26-11-17 ₹5,175.00 +0.76% 124,946
26-11-16 ₹5,136.00 +0.43% 72,809
26-11-13 ₹5,114.00 -3.55% 407,161
26-11-12 ₹5,302.00 -2.68% 1,000,355
26-11-11 ₹5,448.00 +0.92% 148,507
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Alkem Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,136.00INR
Average target price
5,983.60INR
Spread / Average Target
+16.50%
  1. Stock Market
  2. Stocks
  3. ALKEM Stock